40
Participants
Start Date
July 15, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
April 30, 2028
TGRX-678
All patients will be given TGRX-678 240 mg once daily. TGRX-678 is to be taken orally
RECRUITING
Peking University People's Hospital, Beijing
Peking University People's Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Nanfang Hospital, Southern Medical University
OTHER
The First Affiliated Hospital of Soochow University
OTHER
Chinese Academy of Medical Sciences
OTHER
First Affiliated Hospital of Zhejiang University
OTHER
Shenzhen Second People's Hospital
OTHER
Ruijin Hospital
OTHER
Shengjing Hospital
OTHER
Tongji Medical College,Huazhong University of Science &Techonlogy
UNKNOWN
Shenzhen TargetRx, Inc.
INDUSTRY